Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5y49c | — |
Only AS01B adjuvant administered; Inappropriate dose of vaccine administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 58-year-old female patient who received Herpes zoster (Shingrix) (batch number 5y49c, expiry date 04-APR-2027) for prophylaxis. On 11-AUG-2025, the patient received Shingrix. On 11-AUG-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Only AS01B adjuvant administered) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 11-AUG-2025 A nurse practitioner started a chat and informed that a patient was given a dose of AS01b sterile diluent without the antigen component, which led to an inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter wanted to know how should they proceed after this. Reporter informed that such was administered earlier that day. The vaccine administration facility was the same as primary reporter.